In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF.

[1]  H. Ushikoshi,et al.  Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes , 2005, Laboratory Investigation.

[2]  Toshikazu Nakamura,et al.  Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma. , 2005, International journal of oncology.

[3]  David C. Lee,et al.  Heparin-binding Epidermal Growth Factor-like Growth Factor Links Hepatocyte Priming with Cell Cycle Progression during Liver Regeneration* , 2005, Journal of Biological Chemistry.

[4]  F. Kayaselçuk,et al.  Expression of Fas antigen in liver tissue of patients with chronic hepatitis B and C , 2004, European journal of gastroenterology & hepatology.

[5]  Y. Matsuzawa,et al.  Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. , 2003, Gastroenterology.

[6]  T. Hwang,et al.  A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure. , 2003, Life sciences.

[7]  K. Shirouzu,et al.  An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice , 2003, Hepatology.

[8]  W. Russell,et al.  Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. , 2002, Biochemical and biophysical research communications.

[9]  E. Mekada,et al.  Heparin-binding EGF-like growth factor: a juxtacrine growth factor. , 2000, Cytokine & growth factor reviews.

[10]  L. Ferrell.  Liver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems , 2000, Modern Pathology.

[11]  S. Cosulich,et al.  The role of protein kinase B and mitogen‐activated protein kinase in epidermal growth factor and tumor necrosis factor α–mediated rat hepatocyte survival and apoptosis , 2000, Hepatology.

[12]  James M. Wilson,et al.  Intravenous Injection of an Adenovirus Encoding Hepatocyte Growth Factor Results in Liver Growth and Has a Protective Effect against Apoptosis , 2022 .

[13]  M. Serra,et al.  Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.

[14]  S. Higashiyama,et al.  Expression of heparin‐binding epidermal growth factor‐like growth factor in the hepatocytes of fibrotic rat liver during hepatocarcinogenesis , 1999, Journal of gastroenterology and hepatology.

[15]  Toshikazu Nakamura,et al.  Hepatocyte growth factor prevents endotoxin‐induced lethal hepatic failure in mice , 1999, Hepatology.

[16]  Y. Matsuzawa,et al.  Effects of exogenous human heparin-binding epidermal growth factor-like growth factor on DNA synthesis of hepatocytes in normal mouse liver. , 1999, Biochemical and biophysical research communications.

[17]  Y. Kaneda,et al.  Hepatocyte growth factor gene therapy of liver cirrhosis in rats , 1999, Nature Medicine.

[18]  C. Birchmeier,et al.  Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. , 1998, Trends in cell biology.

[19]  R. Schwall,et al.  Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy. , 1998, Human gene therapy.

[20]  K. Matsumoto,et al.  Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. , 1998, Biochemical and biophysical research communications.

[21]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.

[22]  T Nakamura,et al.  Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. , 1997, Biochemical and biophysical research communications.

[23]  S. Nagata,et al.  Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.

[24]  Keiichiro Suzuki,et al.  High expression of heparin‐binding EGF‐like growth factor in rat hepatocarcinogenesis , 1996, International journal of cancer.

[25]  M. Kay,et al.  Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration. , 1996, Human gene therapy.

[26]  D. Morello,et al.  Prometheus' myth revisited: transgenic mice as a powerful tool to study liver regeneration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Y. Matsuzawa,et al.  Expression of heparin-binding EGF-like growth factor in rat liver injured by carbon tetrachloride or D-galactosamine. , 1996, Biochemical and biophysical research communications.

[28]  N. Hayashi,et al.  Fas antigen expression in liver tissues of patients with chronic hepatitis B. , 1996, Journal of hepatology.

[29]  N. Fausto,et al.  Role of growth factors and cytokines in hepatic regeneration , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  Y. Matsuzawa,et al.  Role of heparin‐binding epidermal growth factor–like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy , 1995, Hepatology.

[31]  K. Matsumoto,et al.  Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. , 1995, Journal of biochemistry.

[32]  M. Klagsbrun,et al.  Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. , 1995, Molecular biology of the cell.

[33]  X. -. Chen,et al.  Combination gene therapy for liver metastasis of colon carcinoma in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Y. Matsuzawa,et al.  Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma. , 1994, Gastroenterology.

[35]  Y. Matsuzawa,et al.  Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. , 1994, Biochemical and biophysical research communications.

[36]  N. Fausto,et al.  Transforming growth factor‐α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor‐α and hepatocyte growth factor , 1993 .

[37]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[38]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate , 1993, The Journal of cell biology.

[39]  Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo , 1992, Hepatology.

[40]  M. Klagsbrun,et al.  A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.

[41]  G. Michalopoulos.  Liver regeneration: molecular mechanisms of growth control , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Toshikazu Nakamura,et al.  Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. , 1989, Biochemical and biophysical research communications.